References
- Colditz G. A., Egan K. M., Stampfer M. J. Hormone replacement therapy and risk of breast cancer: results from epidemiological studies. Am. J. Obstet. Gynecol. 1993; 168: 1473–80
- Sillero-Arenas M., Delgado-Rodriguez M., Rodrigues-Canteras R., Bueno-Cavanillas A., Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: a metaanalysis. Obstet. Gynecol 1992; 79: 286–94
- Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R. Hormone replacement therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 1992; 117: 1016–41
- Steinberg K. K., Thacker S. B., Smith S. J., Stroup D. F., Zack M. M., Flanders W. D., Berkelman R. L. A meta-analyses of the effect of estrogen replacement therapy on the risk of breast cancer. J. Am. Med. Assoc 1991; 265: 1985–90
- Dupont W. D., Page D. L. Menopausal estrogen replacement therapy and breast cancer. Arch. Intern. Med. 1991; 151: 67–72
- Armstrong B. K. Oestrogen therapy after the menopause - boon or bane?. Med. J. Aust. 1988; 148: 213–14
- Ettinger B., Friedman G. D., Bush T., Quesenberry C. P. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol 1996; 87: 6–12
- Harris J. R., Lippmann M. E., Veronesi U., Willett W. Breast cancer. N. Engl. J. Med. 1992; 327: 319–28
- Kelsey J. L., Gammon M. D., John E. N. Reproductive factors and breast cancer. Epidemiol. Rev. 1993; 15: 36–47
- Kenemans P., Stampfer M. Hormone replacement therapy and breast cancer. (Guest Editorial). Eur. J. Obstet. Gynecol. Reprod. Biol 1996; 67: 1–4
- Scheele F., Kenemans P., Zweemer R. P. Hormonal replacement therapy and a family history of breast cancer do not act in synergism as risk factors for breast cancer . 1997, Submitted
- Kenemans P. Risk profile based long-term hormone replacement therapy. Eur. Menopause J. 1995; 2: 3–4
- Brinton L. A., Hoover R. N., Szklo M., Fraumeni J. F. Menopausal estrogen use and risk of breast cancer. Cancer 1981; 47: 2517–22
- Buring J. E., Hennekens C. H., Lipnick R. J., Willett W., Stampfer M. J., Rosner B., Peto R., Speizer F. E. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am. J. Epidemiol. 1987; 125: 939–47
- Vogel V. G., Yeomans A., Higginbotham E. Clinical management of women at increased risk for breast cancer. Breast Cancer Research and Treatment 1993; 28: 195–210
- Kenemans P., Scheele F. Hormone replacement therapy in patients at a high risk of breast cancer . 1997, Submitted
- Eden J. A., Bush T., Nand S., Wren B. G. A case control study of continuous combined estrogen-progestin replacement therapy among women with a personal history of breast cancer. Menopause 1995; 2: 67–72
- DiSaia P. J., Grosen E. A., Kurosaki T., Gildea M., Cowan B., Anton-Culver H. Hormone replacement therapy in breast cancer survivors: a cohort study. Am. J. Obstet. Gynecol. 1996; 174: 1494–8